[HTML][HTML] Molecular characterization of bladder cancer in smokers versus nonsmokers

M Joshi, SZ Millis, D Arguello, SL Holder, D Lamm… - European Urology …, 2018 - Elsevier
Smoking is considered an important risk factor for bladder cancer (BC), yet molecular
characterization of BC in nonsmokers has not been extensively studied. Here, we compare …

[PDF][PDF] Molecular profiling of infiltrating urothelial carcinoma of the bladder

SZ Millis, D Bryant, G Basu, R Bender… - Journal of Clinical …, 2014 - carislifesciences.com
Background: Infiltrating urothelial carcinoma (UC) is the most common variant of urinary
bladder cancer. The prognosis for muscle infiltrating or metastatic UC of the bladder is poor …

Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients

D Fantini, R Seiler, JJ Meeks - Urologic Oncology: Seminars and Original …, 2019 - Elsevier
Background Bladder cancer is the fifth most common cancer in the United States and
smoking is the largest known risk factor. Tobacco-derived carcinogens may induce the …

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

LC Kompier, I Lurkin, MNM van der Aa, BWG van Rhijn… - PloS one, 2010 - journals.plos.org
Background Fifty percent of patients with muscle–invasive bladder cancer (MI-BC) die from
their disease and current chemotherapy treatment only marginally increases survival. Novel …

Does Smoking Cessation Reduce Bladder Cancer Recurrence?

KH Gessner, DR Siemens, MA Bjurlin - Journal of Urology, 2022 - journals.lww.com
Smoking status has been associated with both an increased risk of developing bladder
cancer and worse prognosis, but its impact on the risk of nonmuscleinvasive bladder cancer …

Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program

AP Mitra, JE Castelao, D Hawes, DD Tsao‐Wei… - Cancer, 2013 - Wiley Online Library
BACKGROUND: Traditional single‐marker and multimarker molecular profiling approaches
in bladder cancer do not account for major risk factors and their influence on clinical …

Smoking intensity and bladder cancer aggressiveness at diagnosis

ALA Barbosa, SHHM Vermeulen, KK Aben… - PLoS …, 2018 - journals.plos.org
Objective To explore the relation between cigarette smoking intensity and bladder cancer
aggressiveness at first diagnosis. Methods Patients diagnosed with urinary bladder cancer …

Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or metastatic urothelial carcinoma.

N Tripathi, N Sayegh, Y Jo, H Li, R Nussenzveig… - 2022 - ascopubs.org
554 Background: Cigarette smoking is a known risk factor for bladder cancer. Smokers have
been reported to have greater ERCC2-Signature mutations and APOBEC-Signature 13 …

Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer

Y Ling, J Li, L Zhou - International journal of …, 2023 - journals.sagepub.com
Objective Epidemiologic studies have linked smoking to various malignancies, including
bladder cancer, but its underlying biological functions remain elusive. Currently, we aimed to …

Non-urothelial bladder cancer: Genomic alterations and patient outcomes.

F Anari, B Miron, D Henson, D Arguello, ER Plimack… - 2019 - ascopubs.org
399 Background: Adenocarcinoma (ADA) and squamous cell carcinoma (SCC) are rare,
aggressive subtypes of bladder cancer, for which no clear standard of care exists. We report …